JP Sridevi

Devi, P. ., Sridevi, J. ., Kakan, S. ., Saxena, S. ., Jeankumar, V. ., , … Sriram, D. . (2015). Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis. Tuberculosis (Edinburgh, Scotland), 95(6), 786-794. https://doi.org/10.1016/j.tube.2015.04.010

Medapi, B. ., Renuka, J. ., Saxena, S. ., Sridevi, J. ., Medishetti, R. ., Kulkarni, P. ., … Sriram, D. . (2015). Design and synthesis of novel quinoline-aminopiperidine hybrid analogues as Mycobacterium tuberculosis DNA gyraseB inhibitors. Bioorganic & Medicinal Chemistry, 23(9), 2062-78. https://doi.org/10.1016/j.bmc.2015.03.004 (Original work published 2015)

Saxena, S. ., Samala, G. ., Renuka, J. ., Sridevi, J. ., Yogeeswari, P. ., & Sriram, D. . (2015). Development of 2-amino-5-phenylthiophene-3-carboxamide derivatives as novel inhibitors of Mycobacterium tuberculosis DNA GyrB domain. Bioorganic & Medicinal Chemistry, 23(7), 1402-12. https://doi.org/10.1016/j.bmc.2015.02.032 (Original work published 2015)

Devi, P. ., Jogula, S. ., Reddy, A. ., Saxena, S. ., Sridevi, J. ., Sriram, D. ., & Yogeeswari, P. . (2015). Design of Novel Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors: Virtual Screening, Synthesis and In Vitro Biological Activities. Molecular Informatics, 34(2-3), 147-59. https://doi.org/10.1002/minf.201400120

Saxena, S. ., Samala, G. ., Sridevi, J. ., Devi, P. ., Yogeeswari, P. ., & Sriram, D. . (2015). Design and development of novel Mycobacterium tuberculosis L-alanine dehydrogenase inhibitors. European Journal of Medicinal Chemistry, 92, 401-14. https://doi.org/10.1016/j.ejmech.2014.12.046 (Original work published 2015)

Jeankumar, V. ., Reshma, R. ., Janupally, R. ., Saxena, S. ., Sridevi, J. ., Medapi, B. ., … Sriram, D. . (2015). Enabling the (3 + 2) cycloaddition reaction in assembling newer anti-tubercular lead acting through the inhibition of the gyrase ATPase domain: lead optimization and structure activity profiling. Organic & Biomolecular Chemistry, 13(8), 2423-31. https://doi.org/10.1039/c4ob02049a (Original work published 2015)

Pedgaonkar, G. ., Sridevi, J. ., Jeankumar, V. ., Saxena, S. ., Devi, P. ., Renuka, J. ., … Sriram, D. . (2014). Development of benzo d oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA. Bioorganic & Medicinal Chemistry, 22(21), 6134-45. https://doi.org/10.1016/j.bmc.2014.08.031 (Original work published 2014)

Pedgaonkar, G. ., Sridevi, J. ., Jeankumar, V. ., Saxena, S. ., Devi, P. ., Renuka, J. ., … Sriram, D. . (2014). Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis. European Journal of Medicinal Chemistry, 86, 613-27. https://doi.org/10.1016/j.ejmech.2014.09.028 (Original work published 2014)

Devi, P. ., Samala, G. ., Sridevi, J. ., Saxena, S. ., Alvala, M. ., Salina, E. ., … Yogeeswari, P. . (2014). Structure-guided design of thiazolidine derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors. ChemMedChem, 9(11), 2538-47. https://doi.org/10.1002/cmdc.201402171

Jeankumar, V. ., Renuka, J. ., Kotagiri, S. ., Saxena, S. ., Kakan, S. ., Sridevi, J. ., … Sriram, D. . (2014). Gyrase ATPase domain as an antitubercular drug discovery platform: structure-based design and lead optimization of nitrothiazolyl carboxamide analogues. ChemMedChem, 9(8), 1850-9. https://doi.org/10.1002/cmdc.201402035